Submit Manuscript  

Article Details


Establishment of Retinal Degeneration Model in Rat and Monkey by Intravitreal Injection of Sodium Iodate

[ Vol. 18 , Issue. 6 ]

Author(s):

Qingjian Ou, Tong Zhu, Peng Li, Zongyi Li, Li Wang, Chunpin Lian, Hua Xu, Caixia Jin, Furong Gao, Jing-Ying Xu, Juan Wang, Jieping Zhang, Weiye Li, Haibin Tian*, Lixia Lu* and Guo-Tong Xu*   Pages 352 - 364 ( 13 )

Abstract:


Background: Animal models play critical roles in studies of the etiology and therapy of retinal degeneration (RD).

Objective: To establish an RD model without severe systemic side effects in monkeys.

Methods: Cynomolgus monkeys and Sprague-Dawley rats were treated with intravenous and intravitreal sodium iodate (SI). Electroretinographic (ERG) recording, fluorescein fundus angiography (FFA), optical coherence tomography (OCT) and a retinal morphology examination were conducted to evaluate retinal function and structure. ARPE-19 cells were treated with SI to assess cell viability and morphology. Glutathione (GSH) was administered to SI-treated cultured cells and rats for mechanistic studies.

Results: Intravenous SI failed to induce RD in monkeys due to its lethal toxicity and the spontaneous recovery of visual function. However, intravitreal SI injection induced very rapid and severe retinal damage in both monkeys and rats. Different doses of SI were tested in both rats and monkeys, and the SI dose appropriate for the model was calculated. GSH partially rescued oxidative damage to SI-treated retinas. A combination of the appropriate dose of intravitreal SI and intravenous GSH generated moderate subacute RD.

Conclusions: An RD model was established in cynomolgus monkeys by intravitreal SI injection. The key advantages of this model are that lethal SI side effects can be avoided and that the structural and functional changes are similar to those in patients with RD, although the development of RD in the model is too rapid and more severe. An appropriate dose of SI plus systemic GSH generates delayed and moderate RD; this prolonged therapeutic window allows the development of new therapies, such as gene or stem cell-based therapy, for RD.

Keywords:

Retinal degeneration, Animal model, Intravitreal injection, Glutathione, Sodium iodate, therapy.

Affiliation:

Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology, Drexel University College of Medicine, Philadelphia, Pennsylvania, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, Department of Ophthalmology of Shanghai Tenth People's Hospital, and Laboratory of Clinical Visual Science of Tongji Eye Institute, and Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai



Read Full-Text article